Barone R, Nigro F, Triulzi F, Musumeci S, Fiumara A, Pavone L
Division of Paediatric Neurology, Pediatric Clinic, University of Catania, Italy.
Neuropediatrics. 1999 Oct;30(5):270-4. doi: 10.1055/s-2007-973503.
Mucopolysaccharidosis type III (Sanfilippo syndrome) is an autosomal recessive disorder characterised by progressive nervous system involvement with mental retardation, behavioural problems and seizures. Three patients, of 20 months to 12 years of age, were followed up for 3 years both clinically and by using brain magnetic resonance imaging (MRI). Our results suggest that in MPS III patients MRI findings, including atrophy and abnormal or delayed myelination, may precede the onset of overt neurological symptoms. The increasing neurological morbidity is accompanied by different degrees of progressive atrophic changes, mainly affecting the cerebral cortex and the corpus callosum. However, it appears that, across subjects, the rate of MRI changes is unrelated to the severity of the clinical phenotype. On this basis it could be argued that in MPS III the worsening of the neurological symptoms might not necessarily reflect only the progressive cerebral abnormalities detectable by MRI.
Ⅲ型黏多糖贮积症(Sanfilippo综合征)是一种常染色体隐性疾病,其特征为进行性神经系统受累,伴有智力发育迟缓、行为问题和癫痫发作。对3例年龄在20个月至12岁之间的患者进行了为期3年的临床随访,并使用脑磁共振成像(MRI)进行检查。我们的结果表明,在Ⅲ型黏多糖贮积症患者中,MRI表现,包括萎缩以及髓鞘形成异常或延迟,可能先于明显神经症状的出现。神经发病率的增加伴随着不同程度的进行性萎缩性改变,主要影响大脑皮层和胼胝体。然而,似乎在所有受试者中,MRI变化的速率与临床表型的严重程度无关。基于此,可以认为在Ⅲ型黏多糖贮积症中,神经症状的恶化不一定仅反映MRI可检测到的进行性脑异常。